Bumper Offer - Urjas oil Just @ Rs. 1
Derinide 100 Inhaler CFC Free is a prescription medicine that is available as a Inhaler. It is primarily used for the treatment of Asthma, Ulcerative Colitis. The alternative uses of Derinide 100 Inhaler CFC Free have also been explained below.
The optimal dosage of Derinide 100 Inhaler CFC Free is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Derinide 100 Inhaler CFC Free as well, which are listed below. Such side effects of Derinide 100 Inhaler CFC Free normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Derinide 100 Inhaler CFC Free is Safe for pregnant women and Severe for women who are breastfeeding. In addition, Derinide 100 Inhaler CFC Free's effects on the liver, heart and kidney are discussed below in the Derinide 100 Inhaler CFC Free related warnings section.
Other conditions have been mentioned below in the Derinide 100 Inhaler CFC Free contraindications section.
Drug reaction of Derinide 100 Inhaler CFC Free with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Derinide 100 Inhaler CFC Free is considered safe while driving, and is addictive.
Derinide 100 Inhaler CFC Free is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Derinide 100 Inhaler CFC Free is used -
Severe
Moderate
Mild
Is the use of Derinide 100 Inhaler CFC Free safe for pregnant women?
There are no side effects of Derinide in pregnant women.
Is the use of Derinide 100 Inhaler CFC Free safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Derinide. So it is adviced to consult the doctor before using it.
What is the effect of Derinide 100 Inhaler CFC Free on the Kidneys?
Derinide may have mild side effects on the kidneys.
What is the effect of Derinide 100 Inhaler CFC Free on the Liver?
Derinide is rarely harmful for the liver.
What is the effect of Derinide 100 Inhaler CFC Free on the Heart?
Derinide has very mild side effects on the heart.
Derinide 100 Inhaler CFC Free should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Derinide 100 Inhaler CFC Free unless your doctor advises you to do so -
Is this Derinide 100 Inhaler CFC Free habit forming or addictive?
Derinide 100 Inhaler CFC Free is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Derinide 100 Inhaler CFC Free will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Derinide 100 Inhaler CFC Free is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Derinide 100 Inhaler CFC Free is not used to treat mental disorders.
Interaction between Food and Derinide 100 Inhaler CFC Free
Due to a lack of research, nothing can be said about the consequences of taking Derinide 100 Inhaler CFC Free together with food.
Interaction between Alcohol and Derinide 100 Inhaler CFC Free
Due to lack of research, there is no information about the side effects of taking Derinide 100 Inhaler CFC Free with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
